Resolution announcement of the 17th meeting of the third session of the Board of Directors

release time:

2023-08-04 15:56

Stock code: 832316 Securities abbreviation: Tim Biotech Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd
Resolution announcement of the 17th meeting of the third session of the Board of Directors

 

The Company and all members of the Board of Directors warrant that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual responsibility for the authenticity, accuracy and completeness of the contentWith legal liability.

 

1. Convening and attendance at meetings
(1) The convening of the meeting
1. The meeting will be held on May 2023, 4
2. Meeting location: conference room on the third floor of the company
3. Meeting mode: on-site
4. Time and manner of notice of Board meetings: May 2023, 4 by written notice
5. Moderator: Chairman Mr. Cai Tiyuan
6. Attendees: Shi Chunyan, Song Yao, Wang Yanping
7. Legal compliance description of the convening situation:
The convocation and convening of this meeting conforms to the relevant provisions of the Company Law and related laws, administrative regulations and the Articles of Association.
(2) Attendance at the meeting
The meeting shall be attended by 5 directors and 5 directors present and authorized to be present.
2. Deliberation of motions
(2022) Deliberate and adopt the motion on the "<> General Manager Work Report > of the Company's <"
1. Content of the motion:
"2022 General Manager Work Report".
2. Voting result of the motion: 5 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Not.
4. Submission to the general meeting of shareholders for voting:
This proposal does not need to be submitted to the general meeting of shareholders for consideration.
(2022) Deliberate and adopt the motion on the "> of the <> Annual Report of the Board of Directors of the Company <"
1. Content of the motion:
2022 Annual Report on the Work of the Board of Directors.
2. Voting result of the motion: 5 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Not.
4. Submission to the general meeting of shareholders for voting:
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2022) Deliberate and adopt the "> on the Company's <<> Annual Financial Final Report"
1. Content of the motion:
Financial Report 2022.
2. Voting result of the motion: 5 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Not.
4. Submission to the general meeting of shareholders for voting:
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2023) Deliberate and adopt the "> on the Company's <<> Financial Budget Plan"
1. Content of the motion:
2023 Financial Budget Proposal.
2. Voting result of the motion: 5 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Not.
4. Submission to the general meeting of shareholders for voting:
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2022) Deliberate and adopt the motion on the "Summary > of the Company's <2022 Annual Report and <> Annual Report"
1. Content of the motion:
Annual Report 2022 and Summary of Annual Report 2022.
2. Voting result of the motion: 5 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Not.
4. Submission to the general meeting of shareholders for voting:
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2022) Deliberate and adopt the "> on the Company's <> Profit Distribution Plan for the <"
1. Content of the motion:
In order to improve the soundness of finance, enhance the ability to resist risks, achieve sustainable, stable and healthy development of the company, and better safeguard the long-term interests of all shareholders, based on the actual situation of the company, the board of directors decided to:No profit distribution for 2022 will be made.
2. Voting result of the motion: 5 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Not.
4. Submission to the general meeting of shareholders for voting:
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2023) Deliberate and adopt the "On Renewing the Engagement of Grant Thornton (Special General Partnership) for the Company in <>
Audit Body's Bill
1. Content of the motion:
The Company intends to continue to engage Grant Thornton (Special General Partnership) as the Company's auditor for 2023 for one year.
2. Voting result of the motion: 5 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Not.
4. Submission to the general meeting of shareholders for voting:
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(8) Deliberate and adopt the "About Cai Tiyuan Leasing His Own House to Jilin Tian Zheng Biotechnology Co., Ltd."
of the motion
1. Content of the motion:
The company intends to lease Cai Tiyuan's house at No. 88, Building 3 [Building], Hongcheng International Garden Community, No. 1805 Southeast Lake Road, Nanguan District, Changchun City, with a transaction amount of 412,12 yuan per year.
2. Voting result of the motion: 3 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Cai Tiyuan is the controlling shareholder and actual controller of the company, and Cai Tiyuan and director Cai Timing are brothers, so Cai Tiyuan and Cai Timing are affiliated directors and recused themselves from voting.
4. Submission to the general meeting of shareholders for voting:
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2022) Deliberate and pass the "Proposal to Hold the <> Annual General Meeting"
1. Content of the motion:
The Company is requested to convene the 2023 Annual General Meeting of Shareholders in the Company's conference room on May 5, 17 to deliberate on the matters submitted to this General Meeting of Shareholders.
2. Voting result of the motion: 5 votes in favor; 0 votes against; 0 abstentions.
3. Refusal from voting:
Not.
4. Submission to the general meeting of shareholders for voting:
This proposal does not need to be submitted to the general meeting of shareholders for consideration.
3. Catalog of documents for reference
"Resolution of the 17th Meeting of the Third Board of Directors of Jilin Tianzheng Biotechnology Co., Ltd."
Confirmation of Directors, Supervisors, and Senior Management on the 2022 Annual Report

 

Jilin Tianzheng Biotechnology Co., Ltd
board of directors
June 2023, 4